Sinopharm
1099.HK
$3.51
Share price
-0.46%
Change (1 day)
-17.64%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Revenue for Sinopharm (1099.HK)
Revenue in 2023 (TTM): A$93.77 Billion
According to Sinopharm's latest financial reports the company's current revenue (TTM 
) is A$131.91 Billion. an increase over the revenue in the year 2022 that were of A$125.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopharm from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | A$131.91 B | 5.42% |
| 2022 | A$125.12 B | -2.1% |
| 2021 | A$127.80 B | 16.85% |
| 2020 | A$109.37 B | 14.95% |
| 2019 | A$95.15 B | 21.52% |
| 2018 | A$78.30 B | 5.93% |
| 2017 | A$73.91 B | 27.22% |
| 2016 | A$58.10 B | 5.37% |
| 2015 | A$55.13 B | 9.14% |
| 2014 | A$50.51 B | 17.22% |
| 2013 | A$43.09 B | 25.94% |
| 2012 | A$34.21 B | 34.61% |
| 2011 | A$25.42 B | 55.34% |
| 2010 | A$16.36 B | 35.79% |
| 2009 | A$12.05 B | 37.56% |
| 2008 | A$8.76 B | 31.43% |
| 2007 | A$6.66 B | 40.26% |
| 2006 | A$4.75 B |